Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome.

التفاصيل البيبلوغرافية
العنوان:	Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome.
المؤلفون:	Lukowiak TM; Center for Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, NJ, USA. tess.lukowiak@gmail.com., Cahn B; Department of Dermatology, University of Illinois Chicago, Chicago, IL, USA., Samie F; Department of Dermatology, Columbia University, New York, NY, USA., Leffell DJ; Department of Dermatology, Section of Dermatologic Surgery, Yale University, New Haven, CT, USA., Oro A; Department of Dermatology, Stanford University, Redwood City, CA, USA., Kibbi N; Department of Dermatology, Stanford University, Redwood City, CA, USA., Kheterpal M; Department of Dermatology, Duke University, Durham, NC, USA., Babakoohi S; Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC, USA., Khushalani NI; Moffitt Cancer Center, Tampa, FL, USA., Stephenson A; Patient representative, Texas, USA., Ma MS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Shi VJ; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Ahmed A; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Koza E; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Haq M; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Yi MD; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Nadir U; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Yoo S; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Brieva JC; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Lucas J; Department of Dermatology, Cleveland Clinic, Cleveland, OH, USA., Haber R; Department of Dermatology, University of Illinois Chicago, Chicago, IL, USA., Alam M; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
المصدر:	Archives of dermatological research [Arch Dermatol Res] 2024 Jul 05; Vol. 316 (7), pp. 453. Date of Electronic Publication: 2024 Jul 05.
نوع المنشور:	Letter
اللغة:	English
بيانات الدورية:	Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8000462 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-069X (Electronic) Linking ISSN: 03403696 NLM ISO Abbreviation: Arch Dermatol Res Subsets: MEDLINE
أسماء مطبوعة:	Original Publication: Berlin : Springer Verlag
مواضيع طبية MeSH:	Hedgehog Proteins/antagonists & inhibitors , Hedgehog Proteins/metabolism , Basal Cell Nevus Syndrome/drug therapy , Basal Cell Nevus Syndrome/diagnosis , Basal Cell Nevus Syndrome/pathology , Consensus , Skin Neoplasms/drug therapy , Skin Neoplasms/diagnosis , Skin Neoplasms*/pathology, Humans ; Anilides/therapeutic use ; Pyridines/therapeutic use ; Signal Transduction/drug effects
References:	Gorlin RJ (2004) Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 6(6):530–539. (PMID: 10.1097/01.GIM.0000144188.15902.C415545751) Tang JY, Mackay-Wiggan JM, Aszterbaum M et al (2012) Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 366(23):2180–2188. (PMID: 10.1056/NEJMoa1113538226709044362529) Bordeaux J, Blitzblau R, Aasi SZ (2024) Basal cell skin Cancer, Version 3.2024, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw. Sekulic A, Migden MR, Lewis K et al (2015) Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J Am Acad Dermatol 72(6):1021–1026e1028. (PMID: 10.1016/j.jaad.2015.03.02125981002) Migden MR, Guminski A, Gutzmer R et al (2015) Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol 16(6):716–728. (PMID: 10.1016/S1470-2045(15)70100-225981810)
فهرسة مساهمة:	Keywords: Basal cell carcinoma; Basal cell nevus syndrome; Gorlin syndrome; Hedgehog inhibitors; Multidisciplinary care
المشرفين على المادة:	0 (Hedgehog Proteins) 0 (HhAntag691) 0 (Anilides) 0 (Pyridines)
تواريخ الأحداث:	Date Created: 20240705 Date Completed: 20240705 Latest Revision: 20240705
رمز التحديث:	20240705
DOI:	10.1007/s00403-024-03157-z
PMID:	38967654
قاعدة البيانات:	MEDLINE

Find this article in full text from Springer Verlag.

Full Text Finder

الوصف
تدمد:	1432-069X
DOI:	10.1007/s00403-024-03157-z